Home
23andme to share your data with Big Pharma

23andme to share your data with Big Pharma

 Rhesusnegative.net1
Share Button

DNA-testing company 23andMe made headlines last week when it announced that it would share consumers’ anonymized genetic data with pharmaceutical giant GlaxoSmithKline as part of a $300-million deal.

https://www.businessinsider.com/dna-testing-ancestry-23andme-share-data-companies-2018-8?fbclid=IwAR05pYo1JT6VQJ60fZfPs7ZhFhxm0tNsveGS_eRtKv0iZ2p44XP1aWU4PJg

Share Button

About The Author

Rhesusnegative.net

Disclaimer: This blog, all of its content and all of my posts are for Entertainment Purposes Only. Approval of comments does not equal agreement with content. Read at your own risk. Please note that comments will not be approved unless you use your real name. You can use first name only, if no one else has commented under that name before. Otherwise use first name and last initial. If that has been taken, use your full first and last name. No exceptions. Thank you for understanding.

One Comment

  1. Richard Youatt August 15, 2023

    23andMe is a local company to me. IMHO, they have an ethical obligation to share the results of any such collaborative research with their customers. They began on the ethical high ground with the goal of making DNA results available to customers, but then did not handle relations with the Food and Drug Administration (FDA) very well. The FDA was concerned that they were overstating the significance of genetic test results. The company then terminated the distribution of health oriented reports to customers. The GlaxoKline agreement is a further step away from their initial goals.

Add a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.